Haematopoietic stem cell transplant (HCT) and cellular therapy (CT) recipients are profoundly immunocompromised and susceptible to vaccine-preventable infections. Although major societies have published post-HCT vaccination guidelines [1,2,3], consensus and adherence are not universal. CT use is expanding, but vaccination recommendations are not clearly established, and data on late infections and long-term effects remain unclear [4].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Benjamin Teh
Consensus guidelines for antibacterial prophylaxis in patients with neutropenia
Funding: This publication was supported by the National Institute of Allergy and Infectious Diseases of the NIH T32AI118690 and the NHMRC 2013970.
Innovation in active and passive immunisation of people who are immunocompromised: a call to action
Get full text access Log in, subscribe or purchase for full access. References 1. Patel, M ∙ Chen, J ∙ Kim, S ∙ et al. Analysis of MarketScan data for immunosuppressive conditions and hospitalizations for acute respiratory illness, United States Emerg Infect Dis. 2020; 26:1720-1730 2. Harpaz, R ∙ Dahl, RM ∙ Dooling, KL Prevalence of immunosuppression among US adults, 2013 JAMA. 2016; 316:2547-2548 3. Martinson, ML ∙ Lapham, J Prevalence of immunosuppression among US adults JAMA. 2024; 331:880-882 4.
Australia and New Zealand consensus position statement: use of COVID‐19 therapeutics in patients with haematological malignancies
Introduction We are currently living with high rates of transmission of SARS-CoV-2 in the community.
Goals to score: The need for a minimum reporting dataset in studies of infection events in immunocompromised patients
• , , , et al. , Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the Global Burden of Disease Study 2019 . JAMA Oncol. ; ( ): - . • , , , et al.
Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients
Summary Patients can be immunocompromised from a diverse range of disease and treatment factors, including malignancies, autoimmune disorders and their treatments, and organ and stem-cell transplantation. Infections are a leading cause of morbidity and mortality in immunocompromised patients, and the disease treatment landscape is continually evolving.
Vaccine schedule recommendations and updates for patients with hematologic malignancy post‐hematopoietic cell transplant or CAR T‐cell therapy
REVIEW ARTICLE Gemma Reynolds and Victoria G. Hall have equal contribution as first authors. Abstract Revaccination after receipt of a hematopoietic cell transplant (HCT) or cellular therapies is a pillar of patient supportive care, with the potential to reduce morbidity and mortality linked to vaccine-preventable infections.
The long and short of antibiotic management for neutropenic fever in patients with haematological malignancy
Neutropenic fever is a common complication of therapy for haematological malignancy and in about 40% of episodes, no clinical focus or microbiological cause is identified.The optimal strategy for antibiotic management in the setting of neutropenic fever with no identified source is yet to be defined.
Correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine’
Correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine’ Free Mandana Nikpour1, http://orcid.org/0000-0003-0213-5470Benjamin Teh2, Ian P Wicks3,4,5, Marc Pellegrini5,6 1 Department of Medicine at St Vincent's Hospital, University of Melbourne, Fitzroy, Victoria, Australia 2 Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia 3 Clinical...
Correspondence regarding research letter to the editor by Mathian et al, ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine’
Correspondence regarding research letter to the editor by Mathian et al, ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine’ Free Mandana Nikpour1, http://orcid.org/0000-0003-0213-5470Benjamin Teh2, Ian P Wicks3,4,5, Marc Pellegrini5,6 1 Department of Medicine at St Vincent's Hospital, University of Melbourne, Fitzroy, Victoria, Australia 2 Department of Infectious Diseases, Peter MacCallum...
Levofloxacin prophylaxis in patients with myeloma
We commend Mark Drayson and colleagues on their study assessing the impact of levofloxacin prophylaxis on infection burden in patients with myeloma. 1 Drayson MT Bowcock S Planche T et al. Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial. Lancet Oncol.
National cost savings from an ambulatory program for low-risk febrile neutropenia patients in Australia
RESEARCH ARTICLE Previous Next Contents Vol 43(5) Michelle Tew A B E , Daniel Forster A , Benjamin W. Teh B C D and Kim Dalziel A + Author Affiliations - Author Affiliations A Centre for Health Policy, Melbourne School of Population and Global Health, 207 Bouverie Street, Carlton, Vic. 3053, Australia. Email: dpforster@gmail.com; kim.dalziel@unimelb.edu.au B National Centre for Infections in Cancer, Peter MacCallum Cancer Institute, 305 Grattan Street, Melbourne, Vic. 3000, Australia.
Epidemiology of bloodstream infections in patients with myeloma receiving current era therapy
Bloodstream infections (BSIs) are a significant complication of treatment for multiple myeloma (MM). The objective of this study was to define the epidemiology of BSI with current era MM treatment regimens, including immunomodulatory drugs, proteasome inhibitors and autologous haematopoietic stem cell transplantation (ASCT).
Steps to Pre-Order Samsung Gear VR
As many customers show interest in the new virtual reality headset, here are the steps to pre-order Samsung Gear VR. Customers will be able to enjoy many new features from improved design to advanced features. Customers, who have been anxiously waiting for the arrival of the new Samsung Gear Virtual Reality headset, will be happy to hear that the new device is available for pre-order. All buyers have to do is to login on Oculus Store and send online forms to subscribe for a pre-order.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Benjamin
Contact Benjamin, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack